News & Press Releases

The American Lawyer featured Mintz’s addition of the five-partner antitrust litigation team led by Philip Iovieno and including Nicholas Gravante, Jr., Sean O’Shea, Michael Petrella, and Matthew Karlan. The article highlights the team’s focus on high-stakes disputes, including representing major corporations in antitrust opt-out cases, and explains why Mintz was the right fit.

Joanne Hawana was quoted by Endpoints News in an article about how the pharma industry continues to spend hundreds of millions of dollars on ads despite a significant FDA crackdown on misleading consumer ads.  

Member Joanne Hawana was quoted in a Reuters article about the FDA’s plans to restrict GLP-1 ingredients in non-approved compound drugs. The article reports on the agency’s potential enforcement actions involving Hims & Hers and broader regulatory scrutiny of compounded weight-loss medications.

The National Law Journal highlighted the addition of Robert Vlasis to Mintz. He joins as a Co-chair of the firm’s International Trade Commission practice, further strengthening the firm's intellectual property services.

Member Theresa Carnegie shared insights in a Law360 Healthcare Authority article about a federal government bulletin stating that drug manufacturers will be able to sell medications directly to patients through TrumpRx, without violating federal anti-kickback laws. The article sheds light on the potential legal risks associated with excluding telehealth providers, pharmacies, and other parties not covered by the bulletin.

Law360 highlighted the addition of Robert Vlasis to Mintz. The article noted Robert’s deep experience handling 337 Section investigations. He joins as a Co-chair of the firm’s International Trade Commission practice, further strengthening the firm's intellectual property services.